We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




New Approach for the Resection of Low Rectal Cancer

By HospiMedica International staff writers
Posted on 16 Jan 2013
A novel approach to single-incision laparoscopic surgery (SILS) could be used as an effective tool for resection of low rectal cancer.

Researchers at Nanjing University (China) developed a hybrid surgical approach for rectal cancer resection, which was applied in 20 patients with biopsy-proven malignant lesions who were also required to undergo abdominal computed tomography (CT) examination for determining tumor stage, and digital rectal examination on the surgery day. More...
The surgical procedure involved cylindrical abdomino-perineal resection with the patients in the prone jackknife position to achieve peritoneal reflection, followed by SILS performed in the supine position using a homemade single-port device.

The results showed that the average distance from the anal verge was 2.6 cm and the mean tumor diameter confirmed by pathology was 3 cm, with the circumferential margin negative in all the specimens. The mean fabrication and set-up time of the homemade SILS device was 7.75 minutes, and the average operating time was 139 minutes with minimal blood loss; there were no conversions from SILS to conventional laparoscopy. The researchers found that on average, oral intake can often be successfully initiated 7.35 hours after surgery, with the first passage of flatus from the colostomy occurring two and a half days postoperation. During the 6-month-long follow-up stage, no morbidity or mortality was observed, except two patients that experienced poor union in perineum incision. The study was published in the December 2012 issue of Surgical Laparoscopy, Endoscopy & Percutaneous Techniques.

“Cylindrical abdominoperineal resection combined with SILS is a feasible alternative for low rectal cancer, providing benefits like leaving enough exposure for operation, reducing trauma to surrounding organs, almost completely avoiding circumferential involvement, and allowing fast postoperative recovery,” concluded lead author Pan Hua-Feng, MSc.

Low rectal cancer is defined as located within 6 cm of the anal verge, and it requires careful consideration due to the low position in the body. Low rectal cancer means that the anastomotic join is very low in the body and it carries a high risk of fecal incontinence, especially if there has been any neoadjuvant radiotherapy to assist in retaining the sphincters and allows patients to retain function. When this is not possible, an abdomino-perineal excision (APE) is used to remove the rectum, including the anus, requiring the patient have to have a permanent stoma.

Related Links:

Nanjing University




Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
LED Surgical Lamp
ACEMST35/57
Floor‑Mounted Digital X‑Ray System
MasteRad MX30+
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.